Gene therapy for acute myeloid leukemia using sindbis vectors expressing a fusogenic membrane glycoprotein

Cancer Biology and Therapy

Volumn 9, Issue 5, 2010, Pages 350-357

  Tan, Li ^a,b   Xu, Bing ^c   Liu, Ranyi ^a   Liu, Haibo ^a   Tan, Huo ^b   Huang, Wenlin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

AML; GALV; Gene therapy; Laminin R; Sindbis virus

Indexed keywords

GIBBON APE LEUKEMIA VIRUS FUSOGENIC ENVELOPE GLYCOPROTEIN; LAMININ RECEPTOR; SINDBIS VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; COLONY FORMING UNIT GM; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; LEUKEMIA CELL; NONHUMAN; NORMAL HUMAN; SINDBIS VIRUS; TUMOR XENOGRAFT;

ADENOVIRIDAE; GENE THERAPY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; LEUKEMIA, MYELOID, ACUTE; MEMBRANE GLYCOPROTEINS; SINDBIS VIRUS;

EID: 77953723129     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.5.10879     Document Type: Article

References (32)

1. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15:494-501.
2. Hope KJ, Jin L, Dick JE. Human acute myeloid leukemia stem cells. Arch Med Res 2003; 34:507-14.
3. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001; 98:2301-7.
4. Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut JA, et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity and impaired dendritic cell transformation capacities. Cancer Res 2000; 60:4403-11.
5. Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 2000; 60:1492-7.
6. Tan L, Jia H, Liu R, Wu J, Han H, Zuo Y, et al. Inhibition of NFkappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia. Cancer Lett 2009; 273:114-21.
7. Brade AM, Szmitko P, Ngo D, Liu FF, Klamut HJ. Heat-directed tumor cell fusion. Hum Gene Ther 2003; 14:447-61.
8. Ginsberg HS. The ups and downs of adenovirus vectors. Bull NY Acad Med 1996; 73:53-8.
9. Sparer TE, Wynn SG, Clark DJ, Kaplan JM, Cardoza LM, Wadsworth SC, et al. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J Virol 1997; 71:2277-84.
10. Tseng JC, Levin B, Hurtado A, Yee H, Perez de Castro I, Jimenez M, et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 2004; 22:70-7.
11. Tseng JC, Hurtado A, Yee H, Levin B, Boivin C, Benet M, et al. Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 2004; 64:6684-92.
12. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication and evolution. Microbiol Rev 1994; 58:491-562.
13. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol 2000; 74:3366-78.
14. Cook SH, Griffin DE. Luciferase imaging of a neurotropic viral infection in intact animals. J Virol 2003; 77:5333-8.
15. Altman-Hamamdzic S, Groseclose C, Ma JX, Hamamdzic D, Vrindavanam NS, Middaugh LD, et al. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Ther 1997; 4:815-22. (Pubitemid 27380164)
16. Tseng JC, Levin B, Hirano T, Yee H, Pampeno C, Meruelo D. In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst 2002; 94:1790-802.
17. Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 1992; 66:4992-5001.
18. Strauss JH, Wang KS, Schmaljohn AL, Kuhn RJ, Strauss EG. Host-cell receptors for Sindbis virus. Arch Virol Suppl 1994; 9:473-84.
19. Jan JT, Chatterjee S, Griffin DE. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol 2000; 74:6425-32.
20. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, et al. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol 2000; 74:1513-23.
21. Rolls MM, Webster P, Balba NH, Rose JK. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 1994; 79:497-506.
22. Lebedeva I, Fujita K, Nihrane A, Silver J. Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes. J Virol 1997; 71:7061-7. (Pubitemid 27355372)
23. Jie Zhang, Ilya Frolov, Stephen J. Russell. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. J Gene Med 2004; 6:1082-91.
24. Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, et al. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum Gene Ther 2001; 12:811-21.
25. Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, et al. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res 2002; 62:6566-78.
26. Fielding AK, Chapel-Fernandes S, Chadwick MP, Bullough FJ, Cosset FL, Russell SJ. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Hum Gene Ther 2000; 11:817-26.
27. Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy. Cancer Res 2000; 60:6396-402.
28. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 2000; 14:1777-84.
29. Iijima Y, Ohno K, Ikeda H, Sawai K, Levin B, Meruelo D. Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant Sindbis virus vector. Int J Cancer 1999; 80:110-8.
30. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 1995; 130:157-67.
31. Gores GJ, Nieminen AL, Fleishman KE, Dawson TL, Herman B, Lemasters JJ. Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes. Am J Physiol 1998; 255:315-22.
32. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005; 105:4163-9.